ADAMTS13 and COVID-19: Severe COVID-19 patients (needed for mechanical ventilation, n = 19) showed the greatest increase in serum vWF levels and decreases in ADAMTS13 activity compared to moderate (needed for high flow oxygen therapy, n = 17) and mild (needed for low-flow oxygen therapy, n = 14) patients [164].